Literature DB >> 23013408

Towards improved therapies using nanopharmaceuticals: recent patents on pharmaceutical nanoformulations.

Elke Horstkotte1, Kathrin I Odoerfer.   

Abstract

Pharmaceutical formulations that contain nanosized drugs are perceived as "Nanopharmaceuticals" and offer significant benefit for the patient compared to the conventional formulated drugs. There are several advantages of nanoparticular drug formulations such as enhanced solubility and dissolution rate, enhanced oral bioavailability, improved dose proportionality, reduced food effects, suitability for administration by all routes and possibility of sterile filtration due to decreased particle size range. Several nanopharmaceuticals are successfully marketed. Different patented techniques are commercialized to prepare nanopharmaceuticals such as milling, homogenization and precipitation. The focus of the underlying review is to give an overview of those technologies for nanosizing active pharmaceutical ingredients and recently published patents in the field of nanosized pharmaceutics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23013408     DOI: 10.2174/2212798411204030220

Source DB:  PubMed          Journal:  Recent Pat Food Nutr Agric        ISSN: 1876-1429


  1 in total

1.  Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro.

Authors:  Simona Bancos; David L Stevens; Katherine M Tyner
Journal:  Int J Nanomedicine       Date:  2014-12-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.